Recently, our group demonstrated that diabetic animals presented better cardiac function recovery and cellular resistance to ischemic injury than nondiabetics.
These indicators are critical for the prognostic outcome of MI, and their associated effects were especially noticeable in response to CR-SPRC compared with SPRC and captopril, with lower CK and LDH levels, reduced mortality and infarct size and better cardiac function, in addition to higher EF, FS and LVAWs and lower LVIDs, LVIDd, LVs and LVd.
Therefore, it is possible that the better cardiac function has been transitory, and the autonomic dysfunction, more prominent in diabetic group, may lead, in the future, to the cardiovascular damage.
The study demonstrated a 2-hour cooling, rather than 5 or 8 hours, providing not only optimal ejection fraction and myocardial performance index (indicating better cardiac function) but also better survival and neurological outcomes.
These cardiac reprogramming TF-delivered hearts had decreased infarct size and better cardiac function.
When subjected to the same procedure, mice lacking p53 specifically in adipose tissue did not become insulin resistant, showed less adipose tissue inflammation and had better cardiac function.
Therefore, it is possible that the better cardiac function has been transitory in DI rats, and the autonomic dysfunction, more prominent in diabetics, may lead, in the future, to cardiovascular damage, as observed in diabetic patients after an ischemic event.
In tests, post-heart-attack rats that developed heart failure and were treated with SAMβA had better cardiac function — measured by how well the left heart ventricle pumps blood with each heart beat — than rats who weren't treated with SAMβA.
